[1]何颖颖,陈雪生,沈崇岭.倍他司汀联合Epley手法复位对耳石症患者眩晕障碍及前庭症状的影响[J].医学信息,2023,36(13):127-130.[doi:10.3969/j.issn.1006-1959.2023.13.026]
　HE Ying-ying,CHEN Xue-sheng,SHEN Chong-ling.Effect of Betahistine Combined with Epley Manual Reduction on Vertigo Disorder and Vestibular Symptoms in Patients with Otolith[J].Journal of Medical Information,2023,36(13):127-130.[doi:10.3969/j.issn.1006-1959.2023.13.026]
点击复制

倍他司汀联合Epley手法复位对耳石症患者眩晕障碍及前庭症状的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年13期
页码:
127-130
栏目:
论著
出版日期:
2023-07-01

文章信息/Info

Title:
Effect of Betahistine Combined with Epley Manual Reduction on Vertigo Disorder and Vestibular Symptoms in Patients with Otolith
文章编号:
1006-1959（2023）13-0127-04
作者:
何颖颖; 陈雪生; 沈崇岭
（启东市人民医院耳鼻喉咽/头颈外科，江苏 启东 226200）
Author(s):
HE Ying-ying; CHEN Xue-sheng; SHEN Chong-ling
(Department of Otorhinolaryngology-Head and Neck Surgery,Qidong People’s Hospital,Qidong 226200,Jiangsu,China)
关键词:
倍他司汀; Epley手法复位; 耳石症; 眩晕障碍; 前庭症状
Keywords:
Betahistine; Epley manual reduction; Otolith; Vertigo disorder; Vestibular symptoms
分类号:
R764
DOI:
10.3969/j.issn.1006-1959.2023.13.026
文献标志码:
A
摘要:
目的 研究倍他司汀联合Epley手法复位对耳石症患者眩晕障碍及前庭症状的影响。方法 选取2021年1月-2022年5月在我院诊治的86例耳石症患者为研究对象，采用随机数字表法分为对照组和观察组，各43例。对照组采用倍他司汀治疗，观察组在对照组基础上联合Epley手法复位治疗，比较两组临床治疗疗效、眩晕障碍评分、前庭症状（视觉敏感、头晕、恶心、平衡、头痛、眩晕）评分、Berg 平衡评分及复发率。结果 观察组治疗总有效率为93.02%，高于对照组的79.07%（P＜0.05）；两组治疗后眩晕障碍评分均低于治疗前，且观察组低于对照组（P＜0.05）；观察组治疗后视觉敏感、头晕、恶心、平衡、头痛、眩晕评分均低于对照组（P＜0.05）；两组治疗后Berg平衡评分均高于治疗前，且观察组高于对照组（P＜0.05）；随访2个月，观察组复发率为4.65%，低于对照组的20.93%（P＜0.05）。结论 倍他司汀联合Epley手法复位治疗耳石症总有效率高，可有效改善患者眩晕障碍，减轻前庭症状，促进平衡恢复，降低复发率，具有较理想的近远期疗效，值得临床予以重视和应用。
Abstract:
Objective To study the effect of betahistine combined with Epley manual reduction on vertigo disorder and vestibular symptoms in patients with otolith.Methods A total of 86 patients with otolith treated in our hospital from January 2021 to May 2022 were selected as the research objects, and they were divided into control group and observation group by random number table method, with 43 patients in each group. The control group was treated with betahistine, and the observation group was treated with Epley manipulative reduction on the basis of the control group. The clinical efficacy, vertigo disorder score, vestibular symptoms (visual sensitivity, dizziness, nausea, balance, headache, vertigo) score, Berg balance score and recurrence rate were compared between the two groups.Results The total effective rate of treatment in the observation group was 93.02%, which was higher than 79.07% in the control group (P<0.05). The scores of vertigo disorder in the two groups after treatment were lower than those before treatment, and those in the observation group were lower than the control group (P<0.05). After treatment, the scores of visual sensitivity, dizziness, nausea, balance, headache and vertigo in the observation group were lower than those in the control group (P<0.05). The Berg balance scores of the two groups after treatment were higher than those before treatment, and the observation group was higher than the control group (P<0.05). After 2 months of follow-up, the recurrence rate of the observation group was 4.65%, which was lower than 20.93% of the control group (P<0.05).Conclusion Betahistine combined with Epley manipulative reduction has a high total effective rate in the treatment of otolith, which can significantly improve vertigo disorder, reduce vestibular symptoms, promote balance recovery and reduce recurrence rate. Meanwhile, it has ideal short-term and long-term effects and is worthy of clinical attention and application.

参考文献/References:

[1]王逍,李锐.手法复位联合药物治疗30例耳石症患者的临床观察[J].基层医学论坛,2016,20(4):493-495.[2]张国良,石宇芳.手法复位结合药物治疗耳石症眩晕的临床观察[J].医学信息,2016,16(17):261.[3]金曼,王斌全,于文永,等.良性阵发性位置性眩晕手法复位患者残余症状的前庭康复训练[J].护理学杂志,2017,32(10):81-83.[4]张永超,赵洪春,曹瑞娟,等.倍他司汀联合Epley管石复位法治疗后半规管BPPV的临床观察[J].中国处方药,2021,19(6):83-84.[5]张平,葛凤丽.手法复位结合中药制剂治疗耳石症眩晕的有效性和安全性分析[J].河南医学研究,2016,25(7):1252-1253.[6]赵斐斐,牛银花,斯琴塔娜,等.脑益嗪,非那根联合治疗耳石症疗效及复发率影响[J].现代生物医学进展,2020,20(19):3723-3726.[7]杜青,顾宝东,李鑫,等.以“晕痛针”为基础改善耳石症残留症状中情感障碍的临床疗效观察[J].湖北中医杂志,2019,41(5):32-34.[8]付蓉,赵晶,王璐,等.手法复位结合侧卧法治疗水平半规管耳石症[J].中国卫生标准管理,2019,10(1):37-39.[9]刘怡聆,曾莎莎.眩平汤联合西药治疗痰浊中阻型耳源性眩晕的临床疗效及对前庭症状指数评分、眩晕障碍量表评分和跌倒发生情况的影响[J].河北中医,2020,42(5):727-730.[10]宋建春.手法复位联合甲磺酸倍他司汀片治疗耳石症的临床效果[J].临床合理用药杂志,2019,12(36):137-138.[11]仪凡,张根明,刘若凡,等.分阶段治疗良性阵发性位置性眩晕理论探讨[J].中西医结合心脑血管病杂志,2020,18(20):171-172.[12]姚文婷.手法复位联合甲磺酸倍他司汀治疗耳石症临床观察[J].基层医学论坛,2020,24(4):70-71.[13]邓蔚霖.手法复位联合甲磺酸倍他司汀治疗耳石症临床观察[J].中国医药科学,2018,15(1):141-143.[14]陈志凌,陈艳春,吴华为,等.良性阵发性位置性眩晕手法复位并发耳石异常移位的临床分析[J].中国耳鼻咽喉头颈外科,2016,23(12):691-695.[15]金焕庭,李琴,熊奇斌,等.手法复位联合甲磺酸倍他司汀片治疗耳石症的疗效[J].深圳中西医结合杂志,2018,15(6):95-97.[16]杨佩珍,陈彦林,马焱燚,等.良性阵发性位置性眩晕诊治分析[J].中华耳科学杂志,2017,15(6):653-656.[17]薛海龙,李仓霞,段立欣,等.118例创伤后耳石症临床资料分析[J].临床耳鼻咽喉头颈外科杂志,2017,31(10):43-44.[18]杨科敏,王卓彪,孙佳凡.药物治疗与耳石手法复位治疗后半规管良性阵发性位置性眩晕118例疗效观察[J].山西医药杂志,2017,46(20):2482-2483.[19]李兰红,梁毅平.Epley管石复位法联合倍他司汀治疗后半规管良性阵发性位置性眩晕的疗效分析[J].山西医药杂志,2017,46(24):3042-3044.[20]王久敏,王开成,赵元奎,等.自拟涤痰止晕方治疗耳石症手法复位后残留症状的疗效及对症候积分、生活质量的影响[J].四川中医,2021,15(8):109-112.

相似文献/References:

[1]吴达文,郭雪平,谢丽媛.天麻钩藤饮加减治疗肝阳上亢型后循环缺血性眩晕的效果[J].医学信息,2022,35(17):148.[doi:10.3969/j.issn.1006-1959.2022.17.041]
　WU Da-wen,GUO Xue-ping,XIE Li-yuan.Effect of Tianma Gouteng Decoction in the treatment of Posterior Circulation Ischemic Vertigo of Liver-yang Hyperactivity Type[J].Journal of Medical Information,2022,35(13):148.[doi:10.3969/j.issn.1006-1959.2022.17.041]
[2]邵垭杰,毕小江,孙心悦,等.倍他司汀联合盐酸氟桂利嗪治疗耳鸣的Meta分析[J].医学信息,2021,34(04):119.[doi:10.3969/j.issn.1006-1959.2021.04.031]
　SHAO Ya-jie,BI Xiao-jiang,SUN Xin-yue,et al.Meta Analysis of Betahistine Combined with Flunarizine Hydrochloride in the Treatment of Tinnitus[J].Journal of Medical Information,2021,34(13):119.[doi:10.3969/j.issn.1006-1959.2021.04.031]
[3]李书华.倍他司汀治疗原发性HC-BPPV患者复位后残余头晕的效果[J].医学信息,2022,35(01):158.[doi:10.3969/j.issn.1006-1959.2022.01.039]
　LI Shu-hua.Effect of Betahistine on Residual Dizziness After Reduction in Patients with Primary HC-BPPV[J].Journal of Medical Information,2022,35(13):158.[doi:10.3969/j.issn.1006-1959.2022.01.039]

更新日期/Last Update: 1900-01-01